TownSquare Capital’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,548
Closed -$1.16M 1246
2023
Q4
$1.16M Buy
10,548
+2,339
+28% +$242K 0.02% 560
2023
Q3
$828K Buy
8,209
+2,254
+38% +$259K 0.02% 612
2023
Q2
$809K Buy
5,955
+917
+18% +$112K 0.01% 610
2023
Q1
$523K Buy
5,038
+1,030
+26% +$99.6K 0.01% 659
2022
Q4
$355K Buy
4,008
+1,090
+37% +$90.4K 0.01% 753
2022
Q3
$234K Buy
+2,918
New +$275K 0.01% 654

Other funds holding CNMD

TownSquare Capital's CNMD Position: Q1 2024 in Review

TownSquare Capital sold out of CONMED (CNMD) in Q1 2024, closing a stake of 10,548 shares — an estimated $1.16M sold.

TownSquare Capital first reported a position in CNMD in Q3 2022 and held it in 6 quarters. The position peaked at $1.16M in Q4 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • TownSquare Capital reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • TownSquare Capital sold 10,548 CONMED shares in Q1 2024, an estimated $1.16M.
  • TownSquare Capital first reported a position in CONMED in Q3 2022 and held it in 6 quarters.
  • TownSquare Capital's CONMED position peaked at $1.16M in Q4 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on TownSquare Capital's 13F filing for Q1 2024, filed 15 May 2024.